Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M D DeFuria

Showing results (1-10 of 7) with videos related to

Pageof 1
Sort By:
Journal of the National Cancer Institute. Monographs|January 1, 1993
Taxol commercial supply strategyM D DeFuria, Z Horovitz
Antimicrobial Agents and Chemotherapy|February 1, 1974
Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibioticsK E Price, T A Pursiano, M D DeFuria
The Journal of Infectious Diseases|November 1, 1976
Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolatesK E Price, M D DeFuria, T A Pursiano
Cancer Research|February 1, 1980
Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasmsY Daskal, M S Soloway, M D DeFuria, et al.
The Journal of Urology|May 1, 1981
The effect of mitomycin C on superficial bladder cancerM S Soloway, W M Murphy, M D DeFuria, et al.
The Journal of Urology|June 1, 1982
Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patientsG R Prout, P P Griffin, B N Nocks, et al.
Cancer Treatment Reports|February 1, 1980
Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim reportM D DeFuria, R B Bracken, D E Johnson, et al.
Pageof 1

Showing results (1-10 of 7) with videos related to

Sort By:
Pageof 1
Journal of the National Cancer Institute. Monographs|January 1, 1993
Taxol commercial supply strategyM D DeFuria, Z Horovitz
Antimicrobial Agents and Chemotherapy|February 1, 1974
Activity of BB-K8 (amikacin) against clinical isolates resistant to one or more aminoglycoside antibioticsK E Price, T A Pursiano, M D DeFuria
The Journal of Infectious Diseases|November 1, 1976
Amikacin, an aminoglycoside with marked activity against antibiotic-resistant clinical isolatesK E Price, M D DeFuria, T A Pursiano
Cancer Research|February 1, 1980
Morphological effects of mitomycin C administered intravesically to normal mice and mice with N-[4-(5-nitro-2-furyl)-2-thiazolyl]-formamide-induce bladder neoplasmsY Daskal, M S Soloway, M D DeFuria, et al.
The Journal of Urology|May 1, 1981
The effect of mitomycin C on superficial bladder cancerM S Soloway, W M Murphy, M D DeFuria, et al.
The Journal of Urology|June 1, 1982
Intravesical therapy of low stage bladder carcinoma with mitomycin C: comparison of results in untreated and previously treated patientsG R Prout, P P Griffin, B N Nocks, et al.
Cancer Treatment Reports|February 1, 1980
Phase I-II study of mitomycin C topical therapy for low-grade, low stage transitional cell carcinoma of the bladder: an interim reportM D DeFuria, R B Bracken, D E Johnson, et al.
Pageof 1